Trials / Completed
CompletedNCT04916093
Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes
Safety and Efficacy of Sitagliptin, Vildagliptin, and Metformin in Recently Diagnosed Drug-naïve Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Beni-Suef University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The current study aims to investigate Sitagliptin and vildagliptin efficacy and safety compared to metformin as 1st line options for T2D patients.
Detailed description
This is a randomized case-controlled study in which drug-naive type-2 diabetic patients were divided into 3 groups and followed up for three months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vildagliptin 50 MG | Galvus 50 mg oral tablets |
| DRUG | Sitagliptin 100mg | Januvia 100mg oral tablets |
| DRUG | MetFORMIN 1000 Mg Oral Tablet | Glucophage 1000 mg oral tablets |
Timeline
- Start date
- 2019-12-20
- Primary completion
- 2020-06-10
- Completion
- 2020-12-15
- First posted
- 2021-06-07
- Last updated
- 2021-06-07
Locations
1 site across 1 country: Egypt
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04916093. Inclusion in this directory is not an endorsement.